ArticlePharmaceutics2022

Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical Evaluation.

Ameeduzzafar Zafar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.